End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
69.7 TWD | +1.31% | +7.73% | +38.57% |
Business Summary
Number of employees: 76
Sales per Business
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular and Gastrointestinal Drugs
61.3
%
| - | - | 497 | 61.3 % | - |
Reinvestment
38.7
%
| - | - | 314 | 38.7 % | - |
Sales per region
TWD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Taiwan
100.0
%
| 464 | 100.0 % | 811 | 100.0 % | +74.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ssu Yuan Yang
CEO | Chief Executive Officer | - | - |
Chen Ju Kan
DFI | Director of Finance/CFO | - | 31/08/10 |
Shu Ping Huang
ADM | Chief Administrative Officer | - | 31/08/10 |
Jian Rong Huang
SAM | Sales & Marketing | - | 31/03/20 |
Chao Ren Liao
PRN | Corporate Officer/Principal | - | 31/03/19 |
Chia Ling Wu
AUD | Comptroller/Controller/Auditor | - | - |
Te Chu Sun
PRN | Corporate Officer/Principal | - | - |
Hsin Yang Liu
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kang Chi Chou
BRD | Director/Board Member | - | - |
Chuan Lin
CHM | Chairman | 72 | - |
Hsin Yang Liu
PRN | Corporate Officer/Principal | - | - |
Kun Hung Lai
BRD | Director/Board Member | - | 05/10/11 |
Jui Hsun Chen
BRD | Director/Board Member | - | 14/06/18 |
Chao I Chiang
BRD | Director/Board Member | - | - |
Zhi Li Wang
BRD | Director/Board Member | - | 14/06/17 |
Carl Hsiao
BRD | Director/Board Member | - | - |
Yaw-Bin Huang
BRD | Director/Board Member | - | 24/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,398,000 | 13,343,140 ( 34.75 %) | 0 | 34.75 % |
Company contact information
TSH Biopharm Corp., Ltd.
No. 3-1, Park Street 3/F-1, Nangang District
115 03, Taipei
+
http://www.tshbiopharm.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+38.57% | 81.1M | |
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |
- Stock Market
- Equities
- 8432 Stock
- Company TSH Biopharm Corporation Limited